CLINICAL_TRIALS
research
· 2026-02-11
Clinical Trial Update: A Study of GenSci098 in Subjects With Active Thyroid Eye Disease [Phase 1]
Summary
A Phase 1 study evaluating GenSci098 in adults with active thyroid eye disease is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Safety, Tolerability | Phase 1 | Status: RECRUITING